# Study of FFI-1010 in Pediatric Kidney Disease

> **NCT03345316** · PHASE3 · COMPLETED · sponsor: **Fuji Yakuhin Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Children Under 18 Years Old With Kidney Disease

## Interventions

- **DRUG:** FFI-1010

## Key facts

- **NCT ID:** NCT03345316
- **Lead sponsor:** Fuji Yakuhin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345316, "Study of FFI-1010 in Pediatric Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03345316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*